{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T21:15:39Z","timestamp":1788902139359,"version":"build-2803163510"},"reference-count":97,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Parasitology"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.exppara.2026.109164","type":"journal-article","created":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T23:11:08Z","timestamp":1781651468000},"page":"109164","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Nanotechnology in the management of neglected protozoan diseases: Current advances, translational challenges, and future prospects"],"prefix":"10.1016","volume":"287","author":[{"given":"Cornelius Kasie","family":"Ugwuanyi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1249-4226","authenticated-orcid":false,"given":"Adaeze Linda","family":"Onugwu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mercy Chisom","family":"Agu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick Chinedu","family":"Nwosu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chinonyelum","family":"Agbo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franklin Chimaobi","family":"Kenechukwu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony Amaechi","family":"Attama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"16","key":"10.1016\/j.exppara.2026.109164_bib1","doi-asserted-by":"crossref","first-page":"9485","DOI":"10.3390\/ijms23169485","article-title":"In vivo evaluation of praziquantel-loaded solid lipid nanoparticles against S. mansoni infection in preclinical murine models","volume":"23","author":"Adekiya","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.exppara.2026.109164_bib2","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.actatropica.2017.04.029","article-title":"Application of nanotechnology in treatment of leishmaniasis: a review","volume":"172","author":"Akbari","year":"2017","journal-title":"Acta Trop."},{"key":"10.1016\/j.exppara.2026.109164_bib3","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.jgar.2018.09.004","article-title":"Potent in vitro antileishmanial activity of a nanoformulation of cisplatin with carbon nanotubes against Leishmania major","volume":"16","author":"Akhtari","year":"2019","journal-title":"Glob. Aantimicro. Resist"},{"issue":"4","key":"10.1016\/j.exppara.2026.109164_bib4","first-page":"419","article-title":"Field efficacy of topical nano-liposomal amphotericin B (Sina ampholeish\u00ae) alone or in combination with glucantime\u00ae and cryotherapy on human cutaneous leishmaniasis","volume":"18","author":"Alizadeh","year":"2023","journal-title":"Iran. J. Parasitol."},{"issue":"2","key":"10.1016\/j.exppara.2026.109164_bib5","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0012849","article-title":"Redefining the treatment of chagas disease: a review of recent clinical and pharmacological data for a novel formulation of nifurtimox","volume":"19","author":"Altcheh","year":"2025","journal-title":"PLoS Neglected Trop. Dis."},{"issue":"4","key":"10.1016\/j.exppara.2026.109164_bib6","doi-asserted-by":"crossref","first-page":"276","DOI":"10.14218\/JERP.2024.00007","article-title":"Revolutionizing tropical disease treatment: the future of conjugating nanomaterials with drugs","volume":"9","author":"Alvin","year":"2024","journal-title":"J. Explor. Res. Pharmacol."},{"issue":"8","key":"10.1016\/j.exppara.2026.109164_bib7","first-page":"1825","article-title":"Parasitic diseases: liposomes and polymeric nanoparticles versus lipid nanoparticles","volume":"48","author":"Alving","year":"2007","journal-title":"JLR (J. Lipid Res.)"},{"key":"10.1016\/j.exppara.2026.109164_bib9","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.jconrel.2014.11.002","article-title":"Nanobody conjugated PLGA nanoparticles for active targeting of African trypanosomiasis","volume":"197","author":"Arias","year":"2015","journal-title":"J. Contr. Release"},{"issue":"12","key":"10.1016\/j.exppara.2026.109164_bib10","first-page":"2825","article-title":"Toxicity of carbon-based nanomaterials to protozoa and bacteria: biocompatibility and degradation pathways","volume":"34","author":"Aruoja","year":"2015","journal-title":"Environ. Toxicol. Chem."},{"issue":"24","key":"10.1016\/j.exppara.2026.109164_bib11","doi-asserted-by":"crossref","first-page":"8677","DOI":"10.3390\/molecules27248677","article-title":"Polylactide nanoparticles as a biodegradable vaccine adjuvant: a study on safety, protective immunity and efficacy against human leishmaniasis caused by Leishmania major","volume":"27","author":"Ayari-Riabi","year":"2022","journal-title":"Molecules"},{"issue":"4","key":"10.1016\/j.exppara.2026.109164_bib12","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1080\/21645515.2015.1119346","article-title":"A therapeutic nanoparticle vaccine against Trypanosoma cruzi in a BALB\/c mouse model of Chagas disease","volume":"12","author":"Barry","year":"2016","journal-title":"Hum. Vaccines Immunother."},{"issue":"4","key":"10.1016\/j.exppara.2026.109164_bib13","doi-asserted-by":"crossref","first-page":"90","DOI":"10.3390\/diseases10040090","article-title":"Fexinidazole for human African trypanosomiasis, the fruit of a successful public-private partnership","volume":"10","author":"Bernhard","year":"2022","journal-title":"Diseases"},{"key":"10.1016\/j.exppara.2026.109164_bib14","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1016\/S0140-6736(18)31204-2","article-title":"Leishmaniasis","volume":"392","author":"Burza","year":"2018","journal-title":"Lancet"},{"issue":"22","key":"10.1016\/j.exppara.2026.109164_bib15","doi-asserted-by":"crossref","first-page":"5748","DOI":"10.3390\/ijms20225748","article-title":"An overview of drug resistance in protozoal diseases","volume":"20","author":"Capela","year":"2019","journal-title":"Int. J. Mol. Sci."},{"issue":"10","key":"10.1016\/j.exppara.2026.109164_bib16","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1080\/14656566.2019.1609940","article-title":"Current and emerging medications for the treatment of leishmaniasis","volume":"20","author":"Chakravarty","year":"2019","journal-title":"Expert Opin. Pharmacother."},{"key":"10.1016\/j.exppara.2026.109164_bib17","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2021.655435","article-title":"Nanomedicines a hope for Chagas disease","volume":"8","author":"Choudhury","year":"2021","journal-title":"Front. Mol. Biosci."},{"issue":"5","key":"10.1016\/j.exppara.2026.109164_bib18","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0010386","article-title":"Use of benznidazole to treat chronic Chagas disease: an updated systematic review with a meta-analysis","volume":"16","author":"Crespillo-And\u00fajar","year":"2022","journal-title":"PLoS Neglected Trop. Dis."},{"issue":"6","key":"10.1016\/j.exppara.2026.109164_bib19","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1042\/ETLS20170113","article-title":"Drug resistance in protozoan parasites","volume":"1","author":"de Koning","year":"2017","journal-title":"Emerg. Top. Life Sci."},{"issue":"3","key":"10.1016\/j.exppara.2026.109164_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.diagmicrobio.2024.116326","article-title":"Accuracy improvement enzyme-linked immunosorbent assay using superparamagnetic\/polyethylene glycol) nanoparticles for leishmaniasis diagnostic","volume":"109","author":"de Oliveira","year":"2024","journal-title":"Diagn. Microbiol. Infect. Dis."},{"issue":"1","key":"10.1016\/j.exppara.2026.109164_bib21","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1186\/s12879-022-07835-z","article-title":"The efficacy of AuNP-probe conjugate nanobiosensor in non-amplification and amplification forms for the diagnosis of leishmaniasis","volume":"22","author":"Deris","year":"2022","journal-title":"BMC Infect. Dis."},{"issue":"12","key":"10.1016\/j.exppara.2026.109164_bib22","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1080\/17435889.2025.2485024","article-title":"How could the translation of nanotechnology-based therapies revolutionize cutaneous leishmaniasis treatments?","volume":"20","author":"Di Meglio","year":"2025","journal-title":"Nanomedicine"},{"issue":"1","key":"10.1016\/j.exppara.2026.109164_bib24","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1186\/s40249-020-00701-7","article-title":"Strategies supporting the prevention and control of neglected tropical diseases during and beyond the COVID-19 pandemic","volume":"9","author":"Ehrenberg","year":"2020","journal-title":"Infect. Dis. Poverty"},{"issue":"2","key":"10.1016\/j.exppara.2026.109164_bib25","first-page":"197","article-title":"Safety evaluation of topical application of nano-liposomal form of amphotericin B (SinaAmpholeish) on healthy volunteers: phase I clinical trial","volume":"14","author":"Eskandari","year":"2019","journal-title":"Iran. J. Parasitol."},{"issue":"39","key":"10.1016\/j.exppara.2026.109164_bib26","doi-asserted-by":"crossref","first-page":"4759","DOI":"10.1039\/D0AY01516D","article-title":"Optimized DNA-based biosensor for monitoring Leishmania infantum in human plasma samples using biomacromolecular interaction: a novel platform for infectious disease diagnosis","volume":"12","author":"Farshchi","year":"2020","journal-title":"Anal. Methods"},{"key":"10.1016\/j.exppara.2026.109164_bib27","first-page":"1","article-title":"Public-private partnerships and the landscape of neglected tropical disease research: the shifting logic and spaces of knowledge production","author":"Ferpozzi","year":"2023","journal-title":"Minerva"},{"issue":"4","key":"10.1016\/j.exppara.2026.109164_bib28","first-page":"1173","article-title":"Immunological activity of vaccine systems containing liposomal nanocarriers against protozoan-induced diseases: a systematic review","volume":"15","author":"Ferreira","year":"2023","journal-title":"Pharmaceutics"},{"issue":"4","key":"10.1016\/j.exppara.2026.109164_bib30","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0012111","article-title":"The elimination of human African trypanosomiasis: monitoring progress towards the 2021\u20132030 WHO road map targets","volume":"18","author":"Franco","year":"2024","journal-title":"PLoS Neglected Trop. Dis."},{"issue":"1","key":"10.1016\/j.exppara.2026.109164_bib31","doi-asserted-by":"crossref","first-page":"99","DOI":"10.3390\/pharmaceutics15010099","article-title":"Liposomal amphotericin B for treatment of leishmaniasis: from the identification of critical physicochemical attributes to the design of effective topical and oral formulations","volume":"15","author":"Fr\u00e9zard","year":"2023","journal-title":"Pharmaceutics"},{"issue":"9","key":"10.1016\/j.exppara.2026.109164_bib32","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1017\/S0031182020000645","article-title":"Human African trypanosomiasis: the current situation in endemic regions and the risks for non-endemic regions from imported cases","volume":"147","author":"Gao","year":"2020","journal-title":"Parasitology"},{"key":"10.1016\/j.exppara.2026.109164_bib33","doi-asserted-by":"crossref","first-page":"510","DOI":"10.3389\/fchem.2020.00510","article-title":"Evaluation of safety and antileishmanial efficacy of amine functionalized carbon-based composite nanoparticle appended with amphotericin B: an in vitro and preclinical study","volume":"8","author":"Gedda","year":"2020","journal-title":"Front. Chem."},{"key":"10.1016\/j.exppara.2026.109164_bib34","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1186\/s12866-021-02267-2","article-title":"AgNP-PVP-meglumine antimoniate nanocomposite reduces Leishmania amazonensis infection in macrophages","volume":"21","author":"G\u00e9lvez","year":"2021","journal-title":"BMC Microbiol."},{"issue":"5","key":"10.1016\/j.exppara.2026.109164_bib35","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1177\/08853282251350317","article-title":"Methylene blue functionalized ZnO nanoparticles: a promising approach for photodynamic therapy in the treatment of leishmaniasis","volume":"40","author":"Gouvea","year":"2025","journal-title":"J. Biomater. Appl."},{"key":"10.1016\/j.exppara.2026.109164_bib36","first-page":"5351","article-title":"Application of magnetically induced hyperthermia in the model protozoan crithidia fasciculata as a potential therapy against parasitic infections","author":"Graz\u00fa","year":"2012","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.exppara.2026.109164_bib37","doi-asserted-by":"crossref","DOI":"10.1016\/j.jtemb.2024.127404","article-title":"Metallic nanoparticles and treatment of cutaneous leishmaniasis: a systematic review","volume":"83","author":"Guerra","year":"2024","journal-title":"J. Trace Elem. Med. Biol."},{"issue":"10","key":"10.1016\/j.exppara.2026.109164_bib38","doi-asserted-by":"crossref","DOI":"10.1111\/pim.13068","article-title":"Effects of amphotericin b\u2010conjugated functionalized carbon nanoparticles in the treatment of cutaneous leishmaniasis","volume":"46","author":"Heidari\u2010Kharaji","year":"2024","journal-title":"Parasite Immunol."},{"issue":"2","key":"10.1016\/j.exppara.2026.109164_bib39","doi-asserted-by":"crossref","DOI":"10.1111\/pim.70002","article-title":"Solid lipid nanoparticles encapsulated with paromomycin: an effective oral formulation against Leishmania major in mouse model","volume":"47","author":"Heidari\u2010Kharaji","year":"2025","journal-title":"Parasite Immunol."},{"key":"10.1016\/j.exppara.2026.109164_bib40","series-title":"Placebo-Controlled","article-title":"Topical liposomal amphotericin B gel treatment for cutaneous leishmaniasis caused by Leishmania major: a double\u2010blind, randomized","author":"Horev","year":"2023"},{"issue":"4","key":"10.1016\/j.exppara.2026.109164_bib41","doi-asserted-by":"crossref","first-page":"605","DOI":"10.3390\/ani14040605","article-title":"Enhancing control of Leishmania infantum infection: a multi-epitope nanovaccine for durable T-cell immunity","volume":"14","author":"Hurtado-Morillas","year":"2024","journal-title":"Animals"},{"key":"10.1016\/j.exppara.2026.109164_bib42","first-page":"156","article-title":"Development of a topical liposomal formulation of Amphotericin B for the treatment of cutaneous leishmaniasis","volume":"11","author":"Jaafari","year":"2019","journal-title":"Int. J. Parasitol.: Drugs Drug Resist."},{"issue":"3","key":"10.1016\/j.exppara.2026.109164_bib43","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1093\/jac\/dkz473","article-title":"Tolerance to nifurtimox and benznidazole in adult patients with chronic Chagas' disease","volume":"75","author":"Jackson","year":"2020","journal-title":"J. Antimicrob. Chemother."},{"issue":"4","key":"10.1016\/j.exppara.2026.109164_bib44","first-page":"498","article-title":"In vitro and in vivo evaluation of photo-induced antileishmanial activity of indocyanine green-loaded nanomicelles","volume":"28","author":"Jalili","year":"2025","journal-title":"Iran. J. Basic Med. Sci."},{"issue":"1","key":"10.1016\/j.exppara.2026.109164_bib46","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1128\/AAC.01499-13","article-title":"Hepatotoxicity of pentavalent antimonial drug: possible role of residual Sb (III) and protective effect of ascorbic acid","volume":"58","author":"Kato","year":"2014","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.exppara.2026.109164_bib47","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.actatropica.2019.05.018","article-title":"Development of topical liposomes containing miltefosine for the treatment of Leishmania major infection in susceptible BALB\/c mice","volume":"196","author":"Kavian","year":"2019","journal-title":"Acta Trop."},{"key":"10.1016\/j.exppara.2026.109164_bib48","first-page":"126","article-title":"The economic burden of cutaneous leishmaniosis: report from a developing country","volume":"38","author":"Khajedaluee","year":"2024","journal-title":"Med. J. Islam. Repub. Iran"},{"key":"10.1016\/j.exppara.2026.109164_bib49","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2020.120109","article-title":"Development, in vitro and in vivo evaluation of miltefosine loaded nanostructured lipid carriers for the treatment of Cutaneous Leishmaniasis","volume":"593","author":"Khan","year":"2021","journal-title":"Int. J. Pharm."},{"issue":"6","key":"10.1016\/j.exppara.2026.109164_bib50","doi-asserted-by":"crossref","first-page":"838","DOI":"10.3390\/pathogens12060838","article-title":"Metallic nanoparticles and core-shell nanosystems in the treatment, diagnosis, and prevention of parasitic diseases","volume":"12","author":"Kr\u00f3l","year":"2023","journal-title":"Pathogens"},{"issue":"4","key":"10.1016\/j.exppara.2026.109164_bib52","first-page":"228","article-title":"Graphene oxide-based electrochemical biosensors for early diagnosis of parasitic infections","volume":"12","author":"Kumar","year":"2022","journal-title":"Biosensors"},{"key":"10.1016\/j.exppara.2026.109164_bib51","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1016\/j.msec.2017.02.145","article-title":"Development of high efficacy peptide coated iron oxide nanoparticles encapsulated amphotericin B drug delivery system against visceral leishmaniasis","volume":"75","author":"Kumar","year":"2017","journal-title":"Mater. Sci. Eng. C"},{"issue":"10482","key":"10.1016\/j.exppara.2026.109164_bib53","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/S0140-6736(25)00107-2","article-title":"Human African trypanosomiasis","volume":"405","author":"Lejon","year":"2025","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.exppara.2026.109164_bib54","doi-asserted-by":"crossref","first-page":"304","DOI":"10.3390\/polym11020304","article-title":"Chitosan-modified PLGA nanoparticles for control-released drug delivery","volume":"11","author":"Lu","year":"2019","journal-title":"Polymers"},{"key":"10.1016\/j.exppara.2026.109164_bib55","article-title":"Green-synthesised metal nanoparticles for eco-friendly mosquito vector control: a review","volume":"18","author":"Mahmoud","year":"2022","journal-title":"Environ. Nanotechnol. Monit. Manag."},{"issue":"2","key":"10.1016\/j.exppara.2026.109164_bib56","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s40475-021-00232-7","article-title":"A review of leishmaniasis: current knowledge and future directions","volume":"8","author":"Mann","year":"2021","journal-title":"Curr. Tropic. Med. Rep."},{"key":"10.1016\/j.exppara.2026.109164_bib57","doi-asserted-by":"crossref","DOI":"10.1016\/j.pdpdt.2024.104001","article-title":"Photodynamic therapy of cationic and anionic BSA-curcumin nanoparticles on amastigotes of Leishmania braziliensis and Leishmania major and Leishmania amazonensis","volume":"46","author":"Marcolino","year":"2024","journal-title":"Photodiagnosis Photodyn. Ther."},{"issue":"3","key":"10.1016\/j.exppara.2026.109164_bib58","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1590\/abd1806-4841.20198388","article-title":"American tegumentary leishmaniasis: severe side effects of pentavalent antimonial in a patient with chronic renal failure","volume":"94","author":"Marques","year":"2019","journal-title":"Anais brasileiros de dermatologia"},{"issue":"2","key":"10.1016\/j.exppara.2026.109164_bib59","first-page":"50","article-title":"Development and characterization of innovative nifurtimox formulations as therapeutic alternative for Chagas disease","volume":"10","author":"Mazzeti","year":"2025","journal-title":"Trop. Med. Infect. Dis."},{"key":"10.1016\/j.exppara.2026.109164_bib60","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2024.117782","article-title":"Cationic and anionic PLGA-cholesterol hybrid nanoparticles as promising platforms to enhance the trypanocidal efficacy of benznidazole and drug delivery in Trypanosoma cruzi-infected cells","volume":"183","author":"Medeiros","year":"2025","journal-title":"Biomed. Pharmacother."},{"issue":"1","key":"10.1016\/j.exppara.2026.109164_bib61","article-title":"Liposomes containing the imiquimod adjuvant as a vaccine in the cutaneous leishmaniasis model","volume":"7","author":"Mehravaran","year":"2020","journal-title":"Nanomed. J."},{"key":"10.1016\/j.exppara.2026.109164_bib63","article-title":"Nanotechnology-based biosensors for neglected tropical diseases: advances and future directions","volume":"320","author":"Mishra","year":"2020","journal-title":"Sensor. Actuator. B Chem."},{"issue":"3","key":"10.1016\/j.exppara.2026.109164_bib64","first-page":"36","article-title":"Neglected tropical diseases: epidemiology and global burden","volume":"2","author":"Mitra","year":"2017","journal-title":"Trop. Med. Infect. Dis."},{"issue":"6","key":"10.1016\/j.exppara.2026.109164_bib65","first-page":"33","article-title":"Chagas disease in Latin America: an epidemiological update based on 2010 estimates= Maladie de Chagas en Am\u00e9rique latine: le point \u00e9pid\u00e9miologique bas\u00e9 sur les estimations de 2010","volume":"90","author":"mondiale de la Sant\u00e9","year":"2015","journal-title":"Weekly Epidemiological Record= Relev\u00e9 \u00c9pid\u00e9miologique Hebdomadaire"},{"issue":"24","key":"10.1016\/j.exppara.2026.109164_bib66","doi-asserted-by":"crossref","DOI":"10.3390\/jcm11247262","article-title":"Chagas heart disease: beyond a single complication, from asymptomatic disease to heart failure","volume":"11","author":"Montalvo-Ocotoxtle","year":"2022","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.exppara.2026.109164_bib67","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2021.106097","article-title":"Oral administration of buparvaquone nanostructured lipid carrier enables in vivo activity against Leishmania infantum","volume":"169","author":"Monteiro","year":"2022","journal-title":"Eur. J. Pharmaceut. Sci."},{"key":"10.1016\/j.exppara.2026.109164_bib68","volume":"119","author":"Nery","year":"2024"},{"key":"10.1016\/j.exppara.2026.109164_bib69","doi-asserted-by":"crossref","DOI":"10.1155\/2023\/5898160","article-title":"Nanoparticles: a potential and effective method to control insect-borne diseases","volume":"2023","author":"Nie","year":"2023","journal-title":"Bioinorgan. Chem. Appl."},{"issue":"19","key":"10.1016\/j.exppara.2026.109164_bib70","doi-asserted-by":"crossref","first-page":"4751","DOI":"10.1039\/D4NA00474D","article-title":"Biopolymeric and lipid-based nanotechnological strategies for the design and development of novel mosquito repellent systems: recent advances","volume":"6","author":"Nwagwu","year":"2024","journal-title":"Nanoscale Adv."},{"key":"10.1016\/j.exppara.2026.109164_bib71","doi-asserted-by":"crossref","DOI":"10.1186\/s13065-026-01772-7","article-title":"Surface-modified nanocarriers in the design of targeted drug delivery systems for parasitic diseases: a comprehensive review","author":"Nwagwu","year":"2026","journal-title":"BMC Chem."},{"key":"10.1016\/j.exppara.2026.109164_bib72","doi-asserted-by":"crossref","first-page":"308","DOI":"10.55989\/XDUS5159","article-title":"Thermostability and immunostimulatory activity of cationic liposome-based Newcastle disease virus vaccine","volume":"4","author":"Okechukwu","year":"2023","journal-title":"Sci. View J"},{"issue":"1","key":"10.1016\/j.exppara.2026.109164_bib73","first-page":"1428","article-title":"Comparative in vitro transportation of pentamidine across the blood-brain barrier using polycaprolactone nanoparticles and phosphatidylcholine liposomes. Artificial Cells","volume":"47","author":"Omarch","year":"2019","journal-title":"Nanomed. Biotechnol."},{"issue":"9","key":"10.1016\/j.exppara.2026.109164_bib74","doi-asserted-by":"crossref","DOI":"10.1136\/bmjgh-2023-013076","article-title":"A comprehensive framework identifying barriers to global health R&D innovation and access","volume":"8","author":"Ong","year":"2023","journal-title":"BMJ Glob. Health"},{"issue":"9","key":"10.1016\/j.exppara.2026.109164_bib75","doi-asserted-by":"crossref","first-page":"671","DOI":"10.4155\/tde-2021-0039","article-title":"Development of lipid-based microsuspensions for improved ophthalmic delivery of gentamicin sulphate","volume":"12","author":"Onugwu","year":"2021","journal-title":"Ther. Deliv."},{"issue":"4","key":"10.1016\/j.exppara.2026.109164_bib76","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1007\/s40475-023-00304-w","article-title":"Human African trypanosomiasis (sleeping Sickness)\u2014epidemiology, clinical manifestations, diagnosis, treatment, and prevention","volume":"10","author":"Ortiz-Mart\u00ednez","year":"2023","journal-title":"Curr. Tropic. Med. Rep."},{"issue":"1","key":"10.1016\/j.exppara.2026.109164_bib77","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/20477724.2023.2272095","article-title":"Neglected tropical disease (NTD) diagnostics: current development and operations to advance control","volume":"118","author":"Oyeyemi","year":"2024","journal-title":"Pathog. Glob. Health"},{"issue":"9","key":"10.1016\/j.exppara.2026.109164_bib78","first-page":"897","article-title":"Eco-friendly pest management using nanotechnology: present status and future trends","volume":"25","author":"Pavela","year":"2020","journal-title":"Trends Plant Sci."},{"issue":"1","key":"10.1016\/j.exppara.2026.109164_bib79","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1007\/s13346-021-00896-8","article-title":"Efficacy of topical miltefosine formulations in an experimental model of cutaneous leishmaniasis","volume":"12","author":"Peralta","year":"2022","journal-title":"Drug Deliv. Transl. Res."},{"issue":"2","key":"10.1016\/j.exppara.2026.109164_bib80","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0007173","article-title":"The safety and efficacy of miltefosine in the long-term treatment of post-kala-azar dermal leishmaniasis in South Asia \u2013 a review and meta-analysis","volume":"13","author":"Pijpers","year":"2019","journal-title":"PLoS Neglected Trop. Dis."},{"key":"10.1016\/j.exppara.2026.109164_bib81","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jgar.2019.01.023","article-title":"Drug resistance in protozoan parasites: an incessant wrestle for survival","volume":"18","author":"Pramanik","year":"2019","journal-title":"J. Glob. Antimicrob. Resist."},{"issue":"5","key":"10.1016\/j.exppara.2026.109164_bib82","doi-asserted-by":"crossref","first-page":"989","DOI":"10.3390\/pharmaceutics14050989","article-title":"Formulation of amphotericin B in PEGylated liposomes for improved treatment of cutaneous leishmaniasis by parenteral and oral routes","volume":"14","author":"Ramos","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.exppara.2026.109164_bib83","doi-asserted-by":"crossref","first-page":"8659","DOI":"10.2147\/IJN.S262642","article-title":"Evaluation of in vitro and in vivo efficacy of a novel Amphotericin B-Loaded nanostructured lipid carrier in the treatment of Leishmania braziliensis infection","author":"Rebou\u00e7as-Silva","year":"2020","journal-title":"Int. J. Nanomed."},{"issue":"17","key":"10.1016\/j.exppara.2026.109164_bib84","doi-asserted-by":"crossref","DOI":"10.3390\/molecules25174002","article-title":"Activity of amphotericin B-Loaded chitosan nanoparticles against experimental cutaneous leishmaniasis","volume":"25","author":"Riezk","year":"2020","journal-title":"Molecules"},{"issue":"9","key":"10.1016\/j.exppara.2026.109164_bib85","doi-asserted-by":"crossref","first-page":"1822","DOI":"10.3390\/pharmaceutics14091822","article-title":"Solid nanomedicines of nifurtimox and benznidazole for the oral treatment of chagas disease","volume":"14","author":"Rolon","year":"2022","journal-title":"Pharmaceutics"},{"issue":"1","key":"10.1016\/j.exppara.2026.109164_bib86","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1186\/s40001-025-02685-2","article-title":"Nanobiosensors for revolutionizing parasitic infections diagnosis: a critical review to improve global health with an update on future challenges prospect","volume":"30","author":"Sadr","year":"2025","journal-title":"Eur. J. Med. Res."},{"issue":"6","key":"10.1016\/j.exppara.2026.109164_bib87","doi-asserted-by":"crossref","DOI":"10.3390\/nano10061152","article-title":"Amphotericin b loaded polymeric nanoparticles for treatment of leishmania infections","volume":"10","author":"Saqib","year":"2020","journal-title":"Nanomaterials"},{"issue":"10","key":"10.1016\/j.exppara.2026.109164_bib88","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbagen.2023.130416","article-title":"4\u2032, 7-dihydroxyflavone conjugated carbon nanotube formulation demonstrates improved efficacy against Leishmania parasite","volume":"1867","author":"Sasidharan","year":"2023","journal-title":"Biochim. Biophys. Acta Gen. Subj."},{"key":"10.1016\/j.exppara.2026.109164_bib89","article-title":"Encapsulation of benznidazole in nanostructured lipid carriers and increased trypanocidal activity in a resistant Trypanosoma cruzi strain","volume":"59","author":"Silva","year":"2023","journal-title":"Brazilian J. Pharm. Sci."},{"issue":"46","key":"10.1016\/j.exppara.2026.109164_bib90","doi-asserted-by":"crossref","first-page":"27502","DOI":"10.1039\/D0RA04266H","article-title":"Sensible graphene oxide differentiates macrophages and Leishmania: a bio-nano interplay in attenuating intracellular parasite","volume":"10","author":"Singh","year":"2020","journal-title":"RSC Adv."},{"issue":"3","key":"10.1016\/j.exppara.2026.109164_bib91","first-page":"651","article-title":"Nanoemulsion-based essential oils for mosquito control: efficacy and stability assessment","volume":"24","author":"Singh","year":"2021","journal-title":"J. Asia Pac. Entomol."},{"issue":"6","key":"10.1016\/j.exppara.2026.109164_bib92","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics16060800","article-title":"Benznidazole-Loaded polymeric nanoparticles for oral chemotherapeutic treatment of chagas disease","volume":"16","author":"Sousa","year":"2024","journal-title":"Pharmaceutics"},{"issue":"4","key":"10.1016\/j.exppara.2026.109164_bib93","doi-asserted-by":"crossref","first-page":"4011","DOI":"10.1021\/acsnano.4c09566","article-title":"Transforming medicine: Cutting-edge applications of nanoscale materials in drug delivery","volume":"19","author":"Tenchov","year":"2025","journal-title":"ACS Nano"},{"issue":"45","key":"10.1016\/j.exppara.2026.109164_bib94","doi-asserted-by":"crossref","DOI":"10.1021\/acsomega.3c04587","article-title":"Nanotechnology-based strategies in parasitic disease management: from prevention to diagnosis and treatment","volume":"8","author":"Tiwari","year":"2023","journal-title":"ACS Omega"},{"key":"10.1016\/j.exppara.2026.109164_bib95","article-title":"Nanomaterials for diagnosis, treatment, and prevention of human cutaneous leishmaniasis: a review","volume":"12","author":"Vega","year":"2023","journal-title":"OpenNano"},{"key":"10.1016\/j.exppara.2026.109164_bib96","doi-asserted-by":"crossref","DOI":"10.1590\/1678-9199-jvatitd-1441-18","article-title":"Nanoparticulate drug delivery systems for the treatment of neglected tropical protozoan diseases","volume":"25","author":"Volpedo","year":"2019","journal-title":"J. Venomous Anim. Toxins Incl. Trop. Dis."},{"key":"10.1016\/j.exppara.2026.109164_bib98","series-title":"Leishmaniasis","year":"2023"},{"issue":"2","key":"10.1016\/j.exppara.2026.109164_bib100","first-page":"223","article-title":"Comparative efficacy, toxicity and biodistribution of the liposomal amphotericin B formulations fungisome\u00ae and AmBisome\u00ae in murine cutaneous leishmaniasis","volume":"8","author":"Wijnant","year":"2018","journal-title":"Int. J. Parasitol.: Drugs Drug Resist."},{"issue":"9","key":"10.1016\/j.exppara.2026.109164_bib102","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.3390\/molecules25092193","article-title":"Therapeutic nanoparticles and their targeted delivery applications","volume":"25","author":"Yetisgin","year":"2020","journal-title":"Molecules"},{"issue":"1","key":"10.1016\/j.exppara.2026.109164_bib104","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0012735","article-title":"Progress in antileishmanial drugs: mechanisms, challenges, and prospects","volume":"19","author":"Zhang","year":"2025","journal-title":"PLoS Neglected Trop. Dis."},{"issue":"1","key":"10.1016\/j.exppara.2026.109164_bib103","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1128\/mSphere.00340-16","article-title":"Optimized CRISPR-Cas9 genome editing for Leishmania and its use to target a multigene family, induce chromosomal translocation, and study DNA break repair mechanisms","volume":"2","author":"Zhang","year":"2017","journal-title":"mSphere"},{"key":"10.1016\/j.exppara.2026.109164_bib105","first-page":"92","article-title":"Magnetic nanoparticle-based nucleic acid detection for rapid diagnosis of Chagas disease","volume":"1061","author":"Zhao","year":"2019","journal-title":"Anal. Chim. Acta"}],"container-title":["Experimental Parasitology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014489426000718?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014489426000718?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T07:57:43Z","timestamp":1784793463000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014489426000718"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":97,"alternative-id":["S0014489426000718"],"URL":"https:\/\/doi.org\/10.1016\/j.exppara.2026.109164","relation":{},"ISSN":["0014-4894"],"issn-type":[{"value":"0014-4894","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Nanotechnology in the management of neglected protozoan diseases: Current advances, translational challenges, and future prospects","name":"articletitle","label":"Article Title"},{"value":"Experimental Parasitology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.exppara.2026.109164","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"109164"}}